| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0024-3205(83)90285-0 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0024320583902850?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0024320583902850?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 6358755 |
| P2093 | author name string | S. Wilk | |
| P2860 | cites work | On the size of the active site in proteases. I. Papain | Q27860826 |
| Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin | Q28250430 | ||
| Purification and characterization of a thyrotropin-releasing hormone deamidase from rat brain | Q28318956 | ||
| Beta-neo-endorphin, a new hypothalamic "big" Leu-enkephalin of porcine origin: its purification and the complete amino acid sequence | Q34282711 | ||
| Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor | Q34707265 | ||
| Purification of rabbit brain endooligopeptidases and preparation of antienzyme antibodies | Q34708206 | ||
| Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents | Q34936463 | ||
| Substance P and Excitatory Transmitter of Primary Sensory Neurons | Q39102747 | ||
| Postproline cleaving enzyme: identification as serine protease using active site specific inhibitors | Q39154247 | ||
| Enzymes involved in the degradation of thyrotropin releasing hormone (TRH) and luteinizing hormone releasing hormone (LH-RH) in bovine brain | Q39659248 | ||
| Stimulatory effects of substance P on neurite extension and cyclic AMP levels in cultured neuroblastoma cells | Q40160374 | ||
| Degradation of luteinizing hormone—Releasing hormone (LHRH) by brain prolyl endopeptidase with release of des-glycinamide LHRH and glycinamide | Q41160131 | ||
| Purification and properties of a prolyl endopeptidase from rabbit brain | Q41743137 | ||
| Leucylglycinamide Released from Oxytocin by Human Uterine Enzyme | Q42239255 | ||
| Characterization of proline endopeptidase from rat brain | Q42257304 | ||
| Postproline cleaving enzyme: kinetic studies of size and stereospecificity of its active site | Q43760332 | ||
| Use of peptide aldehydes to generate transition-state analogs of elastase | Q44335259 | ||
| Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain | Q48932213 | ||
| Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain | Q48960307 | ||
| Luteinizing hormone-releasing hormone peptidase activities in discrete hypothalamic regions and anterior pituitary of the rat: apparent regulation during the prepubertal period and first estrous cycle at puberty | Q48960326 | ||
| Active Uptake of Substance P Carboxy-Terminal Heptapeptide (5?11) into Rat Brain and Rabbit Spinal Cord Slices | Q49152186 | ||
| The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases. | Q64969139 | ||
| New fluorogenic substrates for a rat brain proline endopeptidase | Q67252714 | ||
| Post-proline-cleaving enzyme in normal and dystrophic human muscle | Q67299887 | ||
| Immunological, physical, and chemical evidence for the identity of brain and kidney post-proline cleaving-enzyme | Q70161369 | ||
| Post-proline cleaving enzyme from lamb brain | Q70189796 | ||
| Specific fluorogenic substrates for the TRF-deamidating post proline cleaving enzyme | Q71494527 | ||
| Purification and properties of a bovine brain thyrotropin-releasing-factor deamidase. A post-proline cleaving enzyme of limited specificity | Q71570363 | ||
| Catabolism of neuropeptides by a brain proline endopeptidase | Q72139175 | ||
| Cleavage of substance P to an N-terminal tetrapeptide and a C-terminal heptapeptide by a post-proline cleaving enzyme from bovine brain | Q72609228 | ||
| Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence | Q72613176 | ||
| Changes in Prolyl Endopeptidase During Maturation of Rat Brain and Hydrolysis of Substance P by the Purified Enzyme | Q72625320 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serine endopeptidase | Q420032 |
| P304 | page(s) | 2149-2157 | |
| P577 | publication date | 1983-11-01 | |
| 1983-11-28 | |||
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Prolyl endopeptidase | |
| P478 | volume | 33 |
| Q74615773 | A 20-kDa domain is required for phosphatidic acid-induced allosteric activation of phospholipase D from Streptomyces chromofuscus |
| Q37709440 | A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept |
| Q21651042 | A Novel Prolyl Endopeptidase Inhibitor, JTP-4819 - Its Behavioral and Neurochemical Properties for the Treatment of Alzheimer's Disease |
| Q52044089 | A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease. |
| Q43758807 | A selective assay for endooligopeptidase A based on the cleavage of fluorogenic substrate structurally related to enkephalin. |
| Q40376087 | An endo-acting proline-specific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides |
| Q41454495 | Angiotensin II inactivation process in cultured mouse spinal cord cells |
| Q48494205 | Angiotensin peptides in brain and pituitary of rat and sheep. |
| Q36310467 | Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats |
| Q42018806 | Benzyloxycarbonylprolylprolinal, a transition-state analogue for prolyl oligopeptidase, forms a tetrahedral adduct with catalytic serine, not a reactive cysteine |
| Q46723167 | Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease |
| Q58582450 | Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms |
| Q24522484 | Catalysis of serine oligopeptidases is controlled by a gating filter mechanism |
| Q54024920 | Characterization of a prolyl endopeptidase (kininase) from human urine using fluorogenic quenched substrates. |
| Q68095529 | Characterization of a prolyl endopeptidase from spinach thylakoids |
| Q115965993 | Current Concepts on Selected Plant Secondary Metabolites With Promising Inhibitory Effects Against Enzymes Linked to Alzheimer's Disease |
| Q37806497 | Degradation of thyrotropin-releasing hormone and luteinising hormone-releasing hormone by enzymes of brain tissue. |
| Q30321432 | Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases. |
| Q28565564 | Distribution of prolyl endopeptidase activities in rat and human brain |
| Q35434067 | Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages |
| Q49142614 | Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain |
| Q48787609 | Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats |
| Q42478368 | Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis |
| Q54160456 | Effects of UPR and ERAD pathway on the prolyl endopeptidase production in Pichia pastoris by controlling of nitrogen source. |
| Q44674563 | Effects of beta-casomorphin-5 on passive avoidance response in mice |
| Q43701518 | Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues |
| Q41848250 | Effects of ionic strength on the catalysis and stability of prolyl oligopeptidase |
| Q48361483 | Effects of polyamines on proline endopeptidase activity in rat brain |
| Q51082340 | Effects of pregnancy and delivery on serum prolyl endopeptidase (PEP) activity: alterations in serum PEP are related to increased anxiety in the early puerperium and to postpartum depression. |
| Q27639555 | Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase. Site specific mutagenesis at the oxyanion binding site |
| Q27642231 | Electrostatic environment at the active site of prolyl oligopeptidase is highly influential during substrate binding |
| Q37346425 | Elucidation of Molecular Mechanism(s) of Cognition Enhancing Activity of Bacomind®: A Standardized Extract of Bacopa Monnieri |
| Q62272846 | Enzymatic inactivation of bradykinin by rat brain neuronal perikarya |
| Q36817565 | Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. |
| Q43965953 | Enzyme inhibitory constituents from Duranta repens |
| Q41674075 | Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism |
| Q44207340 | Fluorometric assay using naphthylamide substrates for assessing novel venom peptidase activities. |
| Q77758251 | Formation of angiotensin-(1-7) from angiotensin II by the venom of Conus geographus |
| Q35040005 | Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor |
| Q51089745 | Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder. |
| Q33756522 | How the Same Core Catalytic Machinery Catalyzes 17 Different Reactions: the Serine-Histidine-Aspartate Catalytic Triad of α/β-Hydrolase Fold Enzymes. |
| Q48622450 | In vitro and in vivo inhibition of prolyl endopeptidase |
| Q42861759 | Inactivation of prolyl endopeptidase by a peptidylchloromethane. Kinetics of inactivation and identification of sites of modification |
| Q38348380 | Inhibitors of TRH-degrading enzymes |
| Q41936316 | Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma |
| Q35871743 | Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin |
| Q73477593 | Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). II. Inhibitory activities and specificity |
| Q51868501 | Localization and subcellular distribution of prolyl oligopeptidase in the mouse placenta. |
| Q44778152 | Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary. |
| Q37871597 | Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010. |
| Q31539063 | Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa |
| Q42082739 | Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages |
| Q40688307 | Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition |
| Q45711471 | Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death |
| Q44604144 | New Prolyl Oligopeptidase Inhibitors Developed from Dicarboxylic Acid Bis(l-prolyl-pyrrolidine) Amides |
| Q44653531 | Ontogeny of Soluble and Particulate Prolyl Endopeptidase Activity in Several Areas of the Rat Brain and in the Pituitary Gland |
| Q44627009 | Ontogeny of prolyl endopeptidase, pyroglutamyl peptidase I, TRH, and its metabolites in rat pancreas |
| Q37291261 | OsPOP5, a prolyl oligopeptidase family gene from rice confers abiotic stress tolerance in Escherichia coli |
| Q33254209 | PREPL: a putative novel oligopeptidase propelled into the limelight |
| Q38136309 | Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia |
| Q30884523 | Peptidomics of prolyl endopeptidase in the central nervous system |
| Q36055312 | Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study |
| Q42226613 | Pharmacokinetics in mice implanted with xenografted tumors after intravenous administration of tasidotin (ILX651) or its carboxylate metabolite |
| Q41740958 | Preventive role of renal kallikrein-kinin system in the early phase of hypertension and development of new antihypertensive drugs |
| Q35092256 | Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs |
| Q56926122 | Probing Substrate Backbone Function in Prolyl Oligopeptidase Catalysis. Large Positional Effects of Peptide Bond Monothioxylation |
| Q34172685 | Proline residues in the maturation and degradation of peptide hormones and neuropeptides |
| Q41684848 | Proline specific peptidases |
| Q50565580 | Prolyl Endopeptidase (PREP) is Associated With Male Reproductive Functions and Gamete Physiology in Mice. |
| Q56593808 | Prolyl Oligopeptidase |
| Q28547816 | Prolyl Oligopeptidase from the Blood Fluke Schistosoma mansoni: From Functional Analysis to Anti-schistosomal Inhibitors |
| Q33215504 | Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting |
| Q47725595 | Prolyl endopeptidase inhibitors from the underground part of Rhodiola sacra S. H. Fu. |
| Q38668992 | Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors |
| Q42861930 | Purification and characterization of human brain prolyl endopeptidase |
| Q30320789 | Rebuttal to Deacon and Holst: "Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1" versus "Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective". |
| Q28205251 | S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies |
| Q52175257 | Screening of crude drug extracts for prolyl endopeptidase inhibitory activity. |
| Q41835005 | Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal |
| Q42145992 | Specificity of neurotensin metabolism by regional rat brain slices. |
| Q27673668 | Structural evidence that puromycin hydrolase is a new type of aminopeptidase with a prolyl oligopeptidase family fold |
| Q47938434 | Structure and localization of the mouse prolyl oligopeptidase gene |
| Q27627477 | Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue |
| Q44494601 | Studies on the transport of thyrotropin-releasing hormone (TRH) analogues in Caco-2 cell monolayers |
| Q91799342 | Study on PREP localization in mouse seminal vesicles and its possible involvement during regulated exocytosis |
| Q58088839 | Subcellular Localization of Prolyl Endopeptidase During the First Wave of Rat Spermatogenesis and in Rat and Human Sperm |
| Q38314464 | Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family |
| Q27639644 | Substrate-dependent competency of the catalytic triad of prolyl oligopeptidase |
| Q95840730 | The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target? |
| Q35333042 | The metabolic serine hydrolases and their functions in mammalian physiology and disease |
| Q30588751 | The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain |
| Q26995817 | The pharmacological landscape and therapeutic potential of serine hydrolases |
| Q35081897 | The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension |
| Q31962055 | The specificity of prolyl endopeptidase from Flavobacterium meningoseptum: mapping the S' subsites by positional scanning via acyl transfer |
| Q41432828 | Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component? |
| Q44131015 | pH-dependent mechanism in the catalysis of prolyl endopeptidase from pig muscle |
Search more.